185 results
Page 8 of 10
40-F
EX-99.2
nkn1nw38205ju
29 May 12
Annual report (Canada)
12:00am
40-F
EX-99.3
sb07s3h3so0sdu 7bb
29 May 12
Annual report (Canada)
12:00am
6-K
EX-99.5
ge2oo2
25 May 12
Current report (foreign)
12:00am
6-K
EX-99.7
ojvzjn8bs4iqyecznv
25 May 12
Current report (foreign)
12:00am
6-K
EX-99
ncl1anpnth4mmpejx
6 Mar 12
Form 6-K Filing Document
12:00am
6-K
EX-99.1
xzjcp
17 Jan 12
Current report (foreign)
12:00am
6-K
EX-99.1
viamc6dxivzw9jgf
14 Oct 11
Current report (foreign)
12:00am
6-K
EX-99.1
1kokl xihzkn
16 Aug 11
Current report (foreign)
12:00am
6-K
EX-99.1
rq2v 1mixl4co2a
17 Jun 11
Current report (foreign)
12:00am
6-K
EX-99.1
wue90ixmfa
16 Jun 11
Current report (foreign)
12:00am
40-F
EX-99.2
7864oi712eh
31 May 11
Annual report (Canada)
12:00am
6-K
EX-99.1
1ba1i
31 May 11
Current report (foreign)
12:00am
6-K
EX-99.5
mx5r9 1kea66
31 May 11
Current report (foreign)
12:00am
40-F
EX-99.5
ondktraq
31 May 11
Annual report (Canada)
12:00am
6-K
EX-99.2
j0fet wsn
31 May 11
Current report (foreign)
12:00am
6-K
EX-99.2
13xlle bj70vhqed
7 Mar 11
Neptune Technologies & Bioressources Inc. Subsidiary Acasti Pharma receives conditionnal approval for listing on TSX-Venture
12:00am
6-K
1b4ir6yndqdd
7 Mar 11
Neptune Technologies & Bioressources Inc. Subsidiary Acasti Pharma receives conditionnal approval for listing on TSX-Venture
12:00am
6-K
EX-99.3
aa2npjrtr g8z
7 Mar 11
Neptune Technologies & Bioressources Inc. Subsidiary Acasti Pharma receives conditionnal approval for listing on TSX-Venture
12:00am
6-K
EX-99.2
t19aquznf7if hgl2n
14 Jan 11
Current report (foreign)
12:00am
6-K
EX-99.1
eqd w5gjb6n1at
14 Jan 11
Current report (foreign)
12:00am